Only 5% of human diseases have an FDA-approved treatment National Institutes of Health

​​90% of health research goes to 10% of the global disease burden Global Forum for Health Research

Billions lack access to vital medicines and vaccines

Our Mission

We aim to build a global open-source pharma ecosystem to develop affordable, evidence-based pharma and biotech interventions in areas of unmet health need, with a special emphasis on the global South

about ospf

support our work

Neglected/Infectious Disease Knowledge Graphs

Open Source Pharma Foundation and Ingentium are collaborating on the implementation of an open information commons for the collaborative development of new disease treatments using an open source methodology, initially focusing on tuberculosis, Chikungunya, and Nipah virus.

visit OSPF-Ingentium applications

By HelloScience
Village Lab

Meet Dr. UC Jaleel, Principal Scientist - Cheminformatics of OSPF in India.  From a small school in rural India to creating a Village Lab that does computational drug discovery, see how he is contributing to the new era of collaboration, and building a community-driven mode of capacity-building and research.

Short Teaser
Medicine For All

​Jaykumar Menon, Co-Founder and Chair of Open Source Pharma Foundation, shares why we need an alternative pharmaceutical system and how OSPF is working to revolutionize the pharma industry. See clips taken at the 3rd Open Source Pharma  Conference (OSP3) in Paris!

view online

March 24, 2019
World Tuberculosis Day

The 3rd Global Open Source Pharma Conference (OSP3) took place in Paris in March 2019. This video was put together at the conference to commemorate World Tuberculosis Day. Have a look!

View online

SUPPORT OUR WORK IN INDIA, USA, AND AROUND THE WORLD

Make a Donation

We seek to discover drugs,
​and a new way to discover drugs.

Learn more about OSPF

OSPF is a proud supporter of the Open Source Pharma movement

OSP3 - Paris - March 2019

OSPF took part in the third conference for the open source pharma movement that was held between March 21st and 23rd, 2019 at the Center for Research and Interdisciplinarity (CRI) in Paris. 

LEARN MORE